Difference between revisions of "Medical liver disease"

Jump to navigation Jump to search
Line 563: Line 563:


[[Cholestasis]]:
[[Cholestasis]]:
*Venlafaxine for depression.<ref name=pmid23073329>{{Cite journal  | last1 = Stadlmann | first1 = S. | last2 = Portmann | first2 = S. | last3 = Tschopp | first3 = S. | last4 = Terracciano | first4 = LM. | title = Venlafaxine-induced cholestatic hepatitis: case report and review of literature. | journal = Am J Surg Pathol | volume = 36 | issue = 11 | pages = 1724-8 | month = Nov | year = 2012 | doi = 10.1097/PAS.0b013e31826af296 | PMID = 23073329 }}</ref>
*Venlafaxine - depression.<ref name=pmid23073329>{{Cite journal  | last1 = Stadlmann | first1 = S. | last2 = Portmann | first2 = S. | last3 = Tschopp | first3 = S. | last4 = Terracciano | first4 = LM. | title = Venlafaxine-induced cholestatic hepatitis: case report and review of literature. | journal = Am J Surg Pathol | volume = 36 | issue = 11 | pages = 1724-8 | month = Nov | year = 2012 | doi = 10.1097/PAS.0b013e31826af296 | PMID = 23073329 }}</ref>
*Thalidomide - [[multiple myeloma]].<ref name=pmid22789729>{{Cite journal  | last1 = Vilas-Boas | first1 = F. | last2 = Gonçalves | first2 = R. | last3 = Sobrinho Simões | first3 = M. | last4 = Lopes | first4 = J. | last5 = Macedo | first5 = G. | title = Thalidomide-induced acute cholestatic hepatitis: case report and review of the literature. | journal = Gastroenterol Hepatol | volume = 35 | issue = 8 | pages = 560-6 | month = Oct | year = 2012 | doi = 10.1016/j.gastrohep.2012.05.007 | PMID = 22789729 }}</ref>


====Specific drugs====
====Specific drugs====